Substituted pyrrolines as kinase inhibitors
US7759380B2 · kind B2 · utility
0Cited by
8References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 8, 2007 |
| Grant date | Jul 20, 2010 |
| Priority date | — |
| Expiry date | May 8, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.